- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01963377
Toward the Development of a Bronchoscope With a Dedicated O2 Channel ?
Evaluation of Feasibility of Dedicated Extra O2-channel in a Bronchoscope.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Comparison of O2 administration using bronchoscope versus nasal cannulae in normal volunteers.
This study will compare partial pressure of oxygen measured in capillary blood (PcO2) at various O2 flow from 0 to 2 and 4 l/min administered using nasal cannulae or bronchoscope. During bronchoscopy, oxygen will be administered throughout the aspirating channel of the scope which extremity will be positioned at mid-tracheal level. After local anesthesia of the airways using lignocaine spray 10% and solution 1%, the bronchoscope will be introduced in seated position using a mouthpiece and placed at mid-tracheal level. Arterial O2-pressure sampled at the earlobe will be measured after incremental O2-supplementation from 0 to 2 and then 4 l/min using a nasal cannula or the aspirating channel of the bronchoscope. At each flow rate, capillary O2-pressure will be measured after 2 minutes. Between each condition of O2-supplementation there will be a pause of 5 minutes of room air breathing. The order of O2-supplementation condition will be selected at random. The whole bronchoscopic procedure should then last about 15 minutes. Additional doses of lignocaine 1% will be instilled in the trachea as requested and O2 saturation and heart rhythm will be monitored continuously during the procedure. Since the subjects are probably able to perceive additional flows in the nose and/or trachea and this may affect the pattern of breathing and the results, air at similar flow rate will be added in the nasal cannulae when O2 is administered using the bronchoscope channel and vice versa such that the subject will be blinded to the way O2 is administered.
This study should allow to demonstrate higher values of capillary O2-pressure during bronchoscopic administration of O2 than when using nasal cannulae. As shown by a recent meta-analysis, partial pressure of O2 measured in capillary blood from the arterialized earlobe (PcO2) is lower than the arterial value but this factor is not important in the present study since it will concentrate on differences in PO2 between the two conditions at similar O2 flow rates that are not affected by this limitation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
BHG
-
Brussels, BHG, Belgium, 1000
- Chu St. Pierre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- healthy subject
Exclusion Criteria:
- younger than 18 years old
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1. Nasal Cannulae / 2. Bronchoscope channel
Supplementation of O2 through will take place first through the aspiration channel of the bronchoscope, in second phase of the study O2-supplementation will be done through nasal cannulae.
|
supplementation of O2 through nasal cannulae during bronchoscopy
supplementation of O2 through aspiration channel of bronchoscope during bronchoscopy
|
Experimental: 1. Bronchoscope channel / 2. Nasal Cannulae
Supplementation of O2 through will take place first through nasal cannulae, in second phase of the study O2-supplementation will be done through the aspiration channel of the bronchoscope.
|
supplementation of O2 through nasal cannulae during bronchoscopy
supplementation of O2 through aspiration channel of bronchoscope during bronchoscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PcO2 difference
Time Frame: 1 hour
|
PcO2 difference after different modes of O2-supplementation (nasal cannulae vs O2 through aspiration channel of bronchoscope) will be measured and compared
|
1 hour
|
Collaborators and Investigators
Investigators
- Principal Investigator: Vincent Ninane, Prof., MD, Chu St. Pierre
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- B076201215478
- AK/12-11-90/4190 (Other Identifier: Comité d'éthique Saint Pierre)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bronchoscopy
-
Paion UK Ltd.Premier Research Group plcCompleted
-
Guangzhou Institute of Respiratory DiseaseCompleted
-
Instituto de Investigación Sanitaria de la Fundación...Ambu A/SCompleted
-
MaineHealthCompleted
-
Pulmonx CorporationCompleted
-
Chang Gung Memorial HospitalCompleted
-
Pusan National University HospitalUnknownBronchoscopyKorea, Republic of
-
University of OklahomaCompletedBronchoscopyUnited States
-
University Hospital, GenevaCentre Valaisan de Pneumologie, CH-3960MontanaCompleted
-
Eisai Inc.PPD; Covance; Quest Pharmaceutical ServicesTerminated
Clinical Trials on O2 through nasal cannulae
-
Bambino Gesù Hospital and Research InstituteUnknown
-
Nova Scotia Health AuthorityNot yet recruitingFluid OverloadCanada
-
Zekai Tahir Burak Women's Health Research and Education...CompletedDeath | Bronchopulmonary Dysplasia
-
St. Olavs HospitalNorwegian University of Science and TechnologyCompleted
-
Poitiers University HospitalCompletedAcute Lung Injury | Acute Respiratory FailureFrance
-
Nova Scotia Health AuthorityTerminatedIntubation Complication | Hypoxemia | PreoxygenationCanada
-
Nova Scotia Health AuthorityDalhousie UniversityCompleted
-
Laval UniversityTerminatedLung Diseases | Chronic Obstructive Pulmonary Disease | Cystic Fibrosis | Pulmonary Hypertension | Interstitial Lung Disease | DyspneaCanada
-
National University Hospital, SingaporeNg Teng Fong General Hospital; Singapore Clinical Research InstituteCompletedIntubation | Oxygen Inhalation TherapySingapore
-
Althaia Xarxa Assistencial Universitària de ManresaTerminated